Courses and Conferences:

Cutting Edge Approaches to Drug Design (CEADD) 

Registration for the Cutting Edge Approaches to Drug Design (CEADD) 2012 meeting is now open.  This meeting, organised by the MGMS, is the latest in a highly successful series of conferences, which have been held in collaboration with the RSC-MMG. The meetings are aimed at those who have an interest in the use of computational chemistry in drug discovery and development.  This includes medicinal chemists, as well as structural biologists and cheminformaticians. The emphasis is on interdisciplinarity in drug discovery and also on evolving tools and techniques and their application in understanding biological systems.

CEADD2012 will be held on Thursday, 26^th April, 2012, at the School of Oriental and African Studies in Russell Square, London.  More details, including the list of speakers and information on how to register, can be found at the conference website (http://www.mgms.org/CEADD2012/index.html).

———————-0000000000000000000————————–

A Practical Introduction to Chemoinformatics

June 12-15, 2012

The University of Sheffield

http://cisrg.shef.ac.uk/chemcourse

The University of Sheffield will be hosting the above short course which is supported by the Chemical Structure Association Trust (CSAT) and the Molecular Graphics and Modelling Society (MGMS). This intensive short course, which has been run since 2000, provides an introduction to the major aspects of Chemoinformatics, with particular emphasis on applications in modern drug discovery. The course will comprise a mixture of hands-on workshops using state-of-the-art software, lectures, and informal discussions and will be delivered by world leaders in the field from academia and industry.

Please register your interest as soon as possible.

Contact Val Gillet (v.gillet@sheffield.ac.uk) or visit http://cisrg.shef.ac.uk/chemcourse

for further details.

———————-0000000000000000000————————–

QSAR2012 conference

http://qsar2012.ut.ee/

15th International Workshop on Quantitative Structure-Activity Relationships (QSAR2012) in Environmental and Health Sciences will bring together experimentalists and modellers from industry, academia, and regulators. It is a place to share information and viewpoints on emerging research results and tools relating to SARs, QSAR-s/QSPR-s, and data analysis for chemicals and pharmaceuticals. The scope of the workshop is not limited to, but involves the following active research areas:

• In Silico Modelling for 21st Century Toxicology
• Prediction of Chronic Toxicity and Organ Level Effects
• Modelling Environmental Toxicity and Fate
• Novel (Q)SAR Approaches and Molecular Descriptors
• Toxicology Data Curation & Mining, Database Ontologies, Knowledge Discovery
• Open Data and Open Software
• Toxicogenomics and Toxicoproteomics, Exploring Mode of Action to Support Predictive Toxicology
• Read-Across as a Solution to Filling Data Gaps
• Computational Aspects of Adverse Outcome Pathways (AOPs)
• Integrating ADME Predictions into Predictive Toxicology
• Chemical Analysis/Screening Systems and Chemo-informatics Solutions for Environmental and Health Sciences
• The Challenge of Predictive Nanotoxicology

Date: June 18-22, 2012

Conference: The 15th International Workshop on Quantitative

Structure-Activity Relationships in Environmental and Health Sciences

Location: Sokos Hotel Viru, Tallinn, Estonia Web site:

———————-0000000000000000000————————–

MM2012 – Queenstown New Zealand – August 2012

http://www.mm2012.org.nz/

Molecular Modelling – 2012: Discovery through Biomolecular Simulation, is the next meeting of the Association of Molecular Modellers of Australasia (AMMA) and will be held in Queenstown, New Zealand as part of Queenstown Research Week (QMB). The main themes of the conference will include computer aided drug design, computational chemistry and cheminformatics. Sessions will include Drug Discovery, Docking and Scoring, QM/MM, Molecular Dynamics, Computational Chemistry and Cheminformatics with a focus on the integration of experiment and theory. We will be holding at least one joint session with the Drug Discovery satellite meeting at QMB.